Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Allogeneic stem cell transplantation for myelofibrosis in 2012.

British journal of haematology - 1 May 2012

McLornan Donal P, Mead Adam J, Jackson Graham, Harrison Claire N

Abstract excerpt

Myelofibrosis (MF) is a heterogeneous disease for which long-term, effective medical therapeutic options are currently limited. The role of allogeneic haematopoietic stem cell transplant (AHSCT) in this population, many of whom are elderly, often provides a challenge with regard to the identification of suitable candidates, timing of transplantation in the disease course and choice of conditioning regimen. This...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hematopoietic Stem Cell Transplantation
Share to Janus Kinase 2
Share to Primary Myelofibrosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Protein Kinase Inhibitors

Share to Recurrence

Share to Splenectomy

Share to Transplantation Conditioning

Share to Transplantation, Homologous

Source

Identifiers

PMID: 22463701
DOI: 10.1111/j.1365-2141.2012.09107.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Allogeneic stem cell transplantation for myelofibrosis in 2012.PMID 22463701Read ↗

Allogeneic haematopoietic cell transplantation for myelofibrosis: a real-life perspective.Semantic proximity Read ↗

Allogeneic Hematopoietic Stem-Cell Transplantation for Myelofibrosis: A Practical Review.Semantic proximity Read ↗

Is allogeneic stem cell transplantation for myelofibrosis still indicated at the time of molecular markers and JAK inhibitors era?Semantic proximity Read ↗

Myelofibrosis: an update on current pharmacotherapy and future directions.Semantic proximity Read ↗

Management of Myelofibrosis: from Diagnosis to New Target Therapies.Semantic proximity Read ↗

Controversies and dilemmas in allogeneic transplantation for myelofibrosis.Semantic proximity Read ↗

Allogeneic Stem Cell Transplant for Myelofibrosis and Myelodysplastic Syndromes: A Contemporary Review.Semantic proximity Read ↗

Allogeneic hematopoietic cell transplantation for patients with myelofibrosis.Semantic proximity Read ↗

Safety and outcome of allogeneic stem cell transplantation in myelofibrosis.Semantic proximity Read ↗

[Research Progress on Effect of JAK Inhibitors on Myelofibrosis- Review].Semantic proximity Read ↗

Myelofibrosis: challenges for preclinical models and emerging therapeutic targets.Semantic proximity Read ↗

How I treat myelofibrosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.